NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.

Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...

To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has adopted Netcall’s Liberty for ...

The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation phase and the start of the cohort expansion ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...

Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...

Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS.

To help HCPs find reliable online answers about medicines, Datapharm collaborated with Medical Information Leaders in Europe ...

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership ...

Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the ...

Rishi Sunak has joined Prostate Cancer Research as an ambassador to champion the charity’s campaign for a national screening ...

The findings of the Stratified Medicine Paediatrics (SMPaeds1) programme, published in the journal Cancer Discovery, ...